Dr. Sennen Hounton, the United Nations Population Fund (UNFPA) Regional Director for West and Central Africa, has urged African governments to invest in local manufacturing of contraceptives. This initiative aims to reduce the continent's heavy reliance on external suppliers and strengthen its health security. The call highlights a critical need for Africa to achieve health sovereignty by producing its own essential medical products.
Dr. Hounton stated that Africa cannot attain true health sovereignty while depending heavily on imported reproductive health commodities. The continent also relies significantly on donor support to meet the needs of women and girls. He stressed the importance of stronger continental cooperation to establish manufacturing facilities capable of producing medical supplies at scale. This would ensure a more resilient and self-sufficient healthcare system across the region.
This push for local manufacturing aligns with broader efforts to bolster Africa's economic independence and reduce its vulnerability to global supply chain disruptions. Ghana, like many African nations, has historically relied on imports for a significant portion of its pharmaceutical and medical supplies. This dependence often leads to higher costs and supply inconsistencies, impacting public health initiatives. The proposed strategy seeks to address these systemic weaknesses and foster a more robust regional economy.
During a press conference in Accra on Wednesday, July 22, Dr. Hounton explicitly stated, "We cannot have sovereignty by tending our hand and asking for others to use their taxpayer money to give us contraception. So we must produce on this continent at scale." He argued that Africa's continued reliance on countries outside the continent for essential health commodities exposes weaknesses in its health systems. This limits its ability to sustainably provide services to its growing population.
The UNFPA Regional Director further explained that individual countries might struggle to establish and sustain large-scale pharmaceutical manufacturing on their own. Therefore, regional collaboration is essential. African governments should come together to create shared manufacturing facilities, rather than relying on production from India, China, or Europe. This collaborative approach would foster a more resilient healthcare system and reduce dependence on imported products and donor-funded programmes.
Dr. Hounton also linked access to contraceptives with broader efforts to improve the lives of women and girls. He emphasized that the ability to make informed reproductive choices has significant social and economic benefits. "When a girl can finish her school, can be protected against child marriage, can choose when to become pregnant, when there is access to this contraception, the life can change and the nation can transform," he noted.
He warned that current investments in reproductive health programmes remain inadequate to meet the needs of women and girls across Africa. Governments are allocating resources, but these amounts are often insufficient. The UNFPA is working with partners, including the African Development Bank, to develop new financing mechanisms. These mechanisms combine concessional loans and grants, allowing countries to access more resources for health investments.
Strengthening local production of health commodities is a crucial part of Africa’s wider agenda to achieve health equity. This ensures that all people, including those in remote communities, have access to essential healthcare services. Dr. Hounton stressed the importance of considering equity when raising capital for these initiatives. This ensures that benefits reach beyond urban centers to all citizens.